We are a leading healthcare campus encompassing all fields of health: from healthcare and research to teaching and management.
Professionalism, commitment and research by professionals on the Campus are the key elements in offering patients excellent care.
We are committed to research as a tool to provide solutions to the daily challenges we face in the field of medical healthcare.
Thanks to our healthcare, teaching and research potential, we work to incorporate new knowledge to generate value for patients, professionals and the organization itself.
We generate, transform and transmit knowledge in all areas of the health sciences, helping to train the professionals of the future.
We are defined by our vocation for communication. We invite you to share everything that happens at Vall d'Hebron Barcelona Hospital Campus, and our doors are always open.
Hospital donations
Research donations
Speaker; Dr. Carlos Briones, Laboratory of Molecular Evolution- Center for Astrobiology (CSIC-INTA, Associated with the NASA Astrobiology Program)
One of the main scientific questions is how life began on Earth... or perhaps on any other planet or satellite. The first scientific reflections on this subject were due to Charles R. Darwin, though the pioneering work in the field was the essay The Origin of Life, published by the Russian biochemist Alexandr I. Oparin in 1924. Since then, numerous theoretical and experimental advances have been made on the origin of life, showing how the basic monomers and biopolymers could have been synthesized under prebiotic conditions. Among the latter, ribonucleic acid (RNA) is particularly relevant, since in the origin of life it was able to function as genotype (molecule with heritable genetic information) and phenotype (thanks to its structural plasticity and functional versatility). During the last decades, experiments of in vitro evolution of RNA (and also of single-stranded DNA) are being carried out to obtain nucleic acids with specific binding capacity to any molecule of interest (called aptamers) or with catalytic activities (ribozymes). Aptamers are especially relevant in biotechnology and biomedicine, with applications in diagnostics and therapeutics. In particular, we are using them as molecular probes in nanobiosensors that allow the ultrasensitive detection of pathogenic viruses. All of these topics will be discussed in this talk.
Host: Dr. Josep Quer, Main researcher-Liver Diseases (VHIR)
Register here to attend by Zoom: https://gencat.zoom.us/j/82583647893
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.